PhD Student
matteociferri.1995@gmail.com
Brain decoding aims to reconstruct external stimuli from brain activity, providing insights into the neural representation of cognitive experiences. Music decoding from functional magnetic resonance imaging (fMRI) is particularly challenging due to the complexity of auditory processing and the temporal limitations of fMRI signals. In this study, we introduce a novel decoding framework that improves the alignment between fMRI activity and latent musical representations extracted using a...
Reconstructing music directly from brain activity provides insight into the neural representations underlying auditory processing and paves the way for future brain-computer interfaces. We introduce a fully data-driven pipeline that combines cross-subject functional alignment with bayesian decoding in the latent space of a diffusion-based audio generator. Functional alignment projects individual fMRI responses onto a shared representational manifold, increasing the performance of...
Red blood cell-derived extracellular particles (RBCEPs) possess many benefits in healthcare applications representing a simple and powerful platform for drug delivery. Nowadays, whether the different methods proposed to produce them could influence their properties remains poorly investigated. We compared three main types of RBCEPs: (i) naturally released during the blood bag storage (EryErythrosomes, EryEs), (ii) produced artificially through RBC sonication (NanoErythrosomes, NanoEs), and (iii)...
CONCLUSION: This study emphasized the critical role of early intervention and oral language competence in developing auditory attention and verbal memory skills in CI children. Efforts to ensure timely intervention and empower language skills after cochlear implantation should guide clinicians' decisions and the implementation of habilitative programs.
CONCLUSIONS: These advancements enable high-purity EV subpopulation isolation, facilitating applications such as identifying cancer biomarkers and developing EV-based targeted therapies.
Created by An:Ca © 2025 Tor Vergata University P.I. 02133971008 – C.F. 80213750583